- Report
- July 2025
Global
From €4379EUR$4,900USD£3,746GBP
- Report
- August 2025
- 193 Pages
Global
From €3168EUR$3,545USD£2,710GBP
€3520EUR$3,939USD£3,011GBP
- Report
- October 2024
- 200 Pages
Global
From €3351EUR$3,750USD£2,867GBP
- Report
- March 2024
- 200 Pages
Global
From €3709EUR$4,150USD£3,173GBP
- Report
- January 2024
- 200 Pages
Global
From €3709EUR$4,150USD£3,173GBP
- Report
- April 2021
- 377 Pages
Global
From €3570EUR$3,995USD£3,054GBP
- Report
- March 2025
- 294 Pages
Global
From €4012EUR$4,490USD£3,433GBP
- Report
- January 2025
- 286 Pages
Global
From €4468EUR$5,000USD£3,822GBP
- Report
- December 2024
- 175 Pages
Global
From €4468EUR$5,000USD£3,822GBP
- Report
- January 2023
- 343 Pages
Global
From €4468EUR$5,000USD£3,822GBP
- Report
- January 2025
- 85 Pages
Saudi Arabia
From €3128EUR$3,500USD£2,676GBP
- Report
- December 2022
- 78 Pages
Global
From €4915EUR$5,500USD£4,205GBP
- Report
- July 2024
- 100 Pages
Global
From €3351EUR$3,750USD£2,867GBP
- Report
- February 2024
- 115 Pages
Global
From €4245EUR$4,750USD£3,631GBP
- Report
- August 2026
- 187 Pages
Global
From €4245EUR$4,750USD£3,631GBP
- Report
- July 2026
- 195 Pages
Global
From €4245EUR$4,750USD£3,631GBP
- Report
- July 2026
- 120 Pages
Global
From €4245EUR$4,750USD£3,631GBP
- Report
- July 2024
- 120 Pages
Global
From €4245EUR$4,750USD£3,631GBP
- Report
- August 2026
- 115 Pages
Global
From €4245EUR$4,750USD£3,631GBP
- Report
- July 2025
- 250 Pages
Asia Pacific
From €3457EUR$3,869USD£2,958GBP

Live attenuated vaccines are a type of vaccine that use a weakened form of a virus or bacteria to stimulate an immune response. These vaccines are designed to replicate the natural infection process, allowing the body to develop immunity without the risk of serious illness. Live attenuated vaccines are typically administered orally or nasally, and are often used to protect against diseases such as measles, mumps, rubella, and rotavirus.
Live attenuated vaccines are generally considered to be safe and effective, and are often used in combination with other vaccines to provide broader protection. They are also cost-effective, as they require fewer doses than other types of vaccines.
Notable companies in the live attenuated vaccine market include Merck & Co., GlaxoSmithKline, Sanofi Pasteur, Pfizer, and Novartis. Show Less Read more